The company, which uses artificial intelligence to develop new treatments, now counts the venture capital firm Thrive Capital ...
Isomorphic Labs raised $600 million in its first external funding round to boost its artificial-intelligence drug design pipeline across multiple therapeutic areas.
Isomorphic Labs, which uses artificial intelligence technologies for drug discovery, has raised $600 million in its first ever external funding round led by Thrive Capital, the startup said on Monday.
Most people start businesses to make more money. Mark Cuban? He's already got the billionaire badge. Now he's out to prove that capitalism doesn't have to be cutthroat. Speaking at WIRED's The Big ...
With local multibillion-dollar mega-projects such as the Gordie Howe International Bridge and the NextStar Energy battery ...
Goldman Sachs estimates that AI drug discovery and breakthroughs like gene editing will add 0.5% to 2.5% to the U.S. gross ...
The patient advocacy startup is set to be valued at more than $300 million after the Series B round, Business Insider has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results